Now FDA Approved
The FDA has approved Zinbryta™ (daclizumab, Biogen and AbbVie) as a disease-modifying therapy for adults with relapsing forms of MS.for more info go to:
Memory rehabilitationReview shows previous measures of memory rehabilitation were not reflective of daily life
Last updated: 9th May 2016
Click link below for more info:
Alternitive to an MRI?
Alternitive to an MRI?Click link below for more info:
A specialized eye test can predict disease progression in MS Retinal thickness can be used as a measure to predict worsening disability in MS Last updated: 3rd May 2016